Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Optellum logo — Early lung cancer diagnosis with AI

Optellum

Early lung cancer diagnosis with AI

Founded 2016 United Kingdom Oxford, United Kingdom 49 employees Series A Total: $15.05M Health Care, Medical Devices +1

General Information

Company Name Optellum
Founded Year 2016
Location United Kingdom Oxford, United Kingdom
Founders / Decision Makers
Team member
Employees 49
Industries Health Care, Medical Devices, Machine Learning
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Optellum. To contact Optellum, visit optellum.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Optellum compare?

A PDF of Optellum and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Optellum soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Optellum

Optellum, a UK-based startup, is revolutionizing early diagnosis and treatment of lung cancer using Artificial Intelligence and Machine Learning. The company's mission is to ensure that every lung cancer patient receives the most effective treatment at the earliest possible stage. Their pioneering Clinical Decision Support software, developed by a team of experts from Oxford's computer vision laboratory, analyzes the world's largest clinical dataset to provide personalized diagnosis and treatment recommendations. With a track record of successful innovation and the backing of a renowned Advisory Board, Optellum secured a significant $14.00M Series A investment from a group of esteemed investors including IQ Capital, Black Opal Ventures, Intuitive, Sir Martin & Lady Audrey Wood, Mercia Fund Managers, and St John's College - Oxford, in September 2022. The company's focus on assembling a high-caliber development team, comprising former engineers from leading technology companies and imaging startup veterans, underscores its commitment to the fight against cancer. For further details, visit http://www.optellum.com/.

Business keywords: medical diagnostics, digital health, cancer, deep learning, big data, patient stratification, medical imaging, lung cancer, early diagnosis, treatment, oncology

Services & Products

AI-powered lung cancer diagnosis and precision care platform

Target Customers

healthcare providers healthcare professionals hospitals health systems

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $14.00M 6
IQ Capital Black Opal Ventures Intuitive
IQ Capital, Black Opal Ventures +4
27 Sep 2022
Seed Round £1.00M 3
IQ Capital Luminous Ventures
IQ Capital, Luminous Ventures +1
16 Jul 2019
Grant €50.00K 1
EASME - EU Executive Agency for SMEs
01 Apr 2016

Optellum Alternatives & Competitors

View All Alternatives
Optellum vs
Prana Surgical
Prana Surgical United States

early intervention, precisely delivered

Venture round
12 employees
Health Care, Medical Devices
Compare Optellum vs Prana Surgical
Optellum vs
HALO Precision Diagnostics
HALO Precision Diagnostics United States

Precision diagnostics for early disease detection.

Series B
180 employees
Enterprise Software, Health Care
Compare Optellum vs HALO Precision Diagnostics
Optellum vs
Qure.ai
Qure.ai United States

Our mission is to make healthcare more affordable and accessible through the power of Artificial Int...

Series D
367 employees
AI, Health Care
View all alternatives

FAQ About Optellum

Early lung cancer diagnosis with AI
Optellum was founded in 2016.
Optellum is headquartered in Oxford, United Kingdom.
Optellum operates in Health Care, Medical Devices and Machine Learning. Its work centres on medical diagnostics, digital health, cancer and deep learning. Its customers include healthcare providers, healthcare professionals and hospitals.
Optellum has approximately 49 employees.
Optellum has completed 3 funding rounds, raising a total of $15.05M. The latest funding stage is Series A.
Optellum offers: AI-powered lung cancer diagnosis and precision care platform.
Top alternatives and competitors to Optellum include Prana Surgical, HALO Precision Diagnostics, Qure.ai, Koning Health, NovaScan. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Optellum and Prana Surgical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Optellum, https://bouncewatch.com/company/optellum, updated 25 February 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes